Press Releases
12/09/2025
Novastra Launches First-in-Human Trial of
Next-Generation Immune Reprogramming Cancer Therapy for Hard-to-Treat Patients
Clinical Trial Shows New Cancer Immunotherapy Effective Against
Drug-Resistant Tumors